Molecular Pharming Market to Grow with Advancing Recombinant Protein Applications During the Forecast Period
Surge in demand
for affordable medicine is driving the growth in Global Molecular Pharming
Market in the forecast period, 2022-2026.
According to TechSci Research report, “Molecular
Pharming Market - Global Industry Size, Share, Trends, Opportunity and
Forecast, 2016-2026 Segmented By Crop Source (Maize, Barley, Tobacco,
Safflower, Rice, Alfalfa), By Technology (Gene Gun, Agroinfiltration,
Electroporation, Agrobacterium-Mediated Gene Transfer, Others), By Application
(Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins &
Protein-Based Materials, Technical Reagents, Nutritional Products, Others), By
End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing
Organizations, Others), By Region”, the global molecular
pharming market would potentially project an impressive growth in the forecast
period, 2022-2026, with an impressive CAGR on the account of rapidly increasing
involvement of technology in the healthcare industry. Moreover, surge in the
demand of the affordable and effective medication is also driving the growth of
the global molecular pharming market in the upcoming five years. Additionally,
increasing instances of chronic diseases among all sections of the society is
further aiding the growth of the global molecular pharming market in the next
five years. Also, demand for herbal and organic products, and medicines is
rapidly increasing thereby supporting the growth of the global molecular
pharming market in the future five years. Furthermore, the rising awareness
about the ayurvedic medicines, advantages of plants-based medication and herbal
products is further substantiating the growth of the global molecular pharming
market in the forecast period until 2026.
Molecular pharming is defined as the production of recombinant
pharmaceuticals through plant biotechnology. The process has the potential to
transform the pharmaceutical sector by making available of the drugs that are
highly effective as well as affordable to every section of the society. The use
of plants to express proteins is more practical, safe, efficient, and cost
effective. The production of the biologics in the plant system to minimize the
cost of microbial systems is termed as molecular pharming.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Molecular pharming Market"
https://www.techsciresearch.com/report/molecular-pharming-market/7873.html
The global molecular pharming market segmentation
is based on crop source, technology, application, end user, competitional
landscape, and regional distribution. Based on application, the market is
further segmented into recombinant antibodies, hormones, vaccines, industrial
enzymes, proteins & protein-based materials, technical reagents,
nutritional products, and others. Recombinant antibodies are monoclonal antibodies
which are generated in vitro using synthetic genes. The production of
recombinant proteins in the plant via process of molecular pharming can produce
large quantities of medicinal polypeptides for the diagnosis and treatment of
many diseases. For the production of antibodies in transgenic plants, plants are
infected by engineered plant viruses and multiplied in plant cell culture.
Plants hormones bring the qualities of rapid growth and proteins produced
increases the plant growth the property is used in the pharmaceutical products
too. Similarly, plant vaccines are also more beneficial, long lasting, have
better result thus being used in the molecular pharming.
Based on end user, the market is further bifurcated
into biotechnology & pharmaceutical companies, contract manufacturing
organizations, and others. Biotechnology & pharmaceutical companies are
anticipated to hold the largest revenue shares of the market and dominate the
market segment in the upcoming five years on the account of increased uses of
molecular pharming in production of precision medicine, genomic medicine, and
to reduce the manufacturing cost of the pharmaceuticals and related products.
Moreover, the advancing technologies are further aiding the growth of the
global molecular pharming market in the next five years. Surging demands from
the pharmaceutical industries is also substantiating the growth of the global
molecular pharming market in the next five years.
Meristem Therapeutics S.A. (Ventria Bioscience),
Moolec Science Limited, Leaf Systems International Limited, Agrenvec S.L.,
Diamante SRL, ORF Genetics, Pfizer, Inc., Medicago Inc., Protalix
Biotherapeutics, Inc., ProdiGene Inc., are some of the market players holding
the major shares of the global molecular pharming market. Market players are
actively involved in the research and technological development in the product
developments. The advanced technology has made it possible for the industry to
provide excellent services through molecular pharming. Further advancement
would aid the market value and brand establishment in the future five years.
New market players may focus on the research and development to provide options
that satisfies the consumer demand as well as benefits the market players in
building their brand value. Other competitive strategies include mergers &
acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7873
Customers can also request for
10% free customization on this report.
“North America is the
most promising region in terms of the future market growth. The market growth
is anticipated on the backbone of advancing healthcare industry in the
countries like United States, Canada. Moreover, research and technological
advancement is rapidly increasing in the region and aiding the growth of the
market. The combination of technology for the advanced plant biotechnological
practices combined with the advanced agricultural practices is also aiding the
growth of the global molecular pharming market in the future five years. New
market players must focus on the extended research and advancing technologies
using the plant system making it efficient and cheaper option for the mass
production of the various pharmaceutical and biologics. Financial investment
and favorable policies for the pharmaceutical production would also support the
future market growth,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based Global management consulting firm.
“Global Molecular Pharming
Market - Global Industry Size, Share, Trends, Opportunity and Forecast,
2016-2026 Segmented By Crop Source (Maize, Barley, Tobacco, Safflower, Rice,
Alfalfa), By Technology (Gene Gun, Agroinfiltration, Electroporation,
Agrobacterium-Mediated Gene Transfer, Others), By Application (Recombinant
Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins &
Protein-Based Materials, Technical Reagents, Nutritional Products, Others), By
End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing
Organizations, Others), By Region”, has evaluated the future growth potential
of global molecular pharming and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in global molecular
pharming market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/